Novavax shares boosted on bird flu vaccine hopes

Shares of Novavax surged on Monday after an analyst touted its experimental bird flu vaccine as "the best." Company shares have soared 58 percent since the beginning of this year.

- read the AP report

PLUS: More than half of the U.S. budget for bird flu will be devoted to developing new vaccines. Report

ALSO: Health officials confirmed that three people in Azerbaijan have died of bird flu, pushing the global death toll past 100. Report